Evidence map›Paper›PMID 22613816›Full record

ArticleComparative biochemistry and physiology. Part B, Biochemistry & molecular biology2012

Comparative enzymology of (2S,4R)4-fluoroglutamine and (2S,4R)4-fluoroglutamate.

Arthur J L Cooper, Boris F Krasnikov, John T Pinto, Hank F Kung, Jianyong Li, Karl Ploessl

Abstract read
In one paragraph

Article in Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.1field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. The Potential Utility of (2S,4R)-4-[Molecular imaging and biology · 2025
    Article
  2. Kinetic Modeling ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Article
  3. Pharmacokinetic Assessment ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020
    Article
  4. Article
  5. Metabolic Imaging of Glutamine in Cancer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2017
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Arthur J L CooperDepartment of Biochemistry and Molecular Biology, New York Medical College, Valhalla, NY 10595, USA. arthur_cooper@nymc.edu
Boris F Krasnikov
John T Pinto
Hank F Kung
Jianyong Li
Karl Ploessl
New York Medical College · USUniversity of Pennsylvania · USVirginia Tech · US

Funding

Novel PET imaging agents for understanding glutamine addiction in cancerR01CA164490 · NCI · UNIVERSITY OF PENNSYLVANIA · PI CHODOSH, LEWIS A, KUNG, HANK F · 2011 to 2015
$4.0M
MECHANISM OF GLUTATHIONE CONJUGATE DEPENDENT TOXICITYR01ES008421 · NIEHS · WINIFRED MASTERSON BURKE MED RES INST · PI COOPER, ARTHUR JOSEPH · 1997 to 2007
$2.0M
Kynurenic Acid Synthesis in Mouse BrainR01NS062836 · NINDS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI LI, JIANYONG · 2009 to 2010
$851k
NCI NIH HHS CA-164490NCI NIH HHS R01 CA164490NIEHS NIH HHS ES-008421NIEHS NIH HHS R01 ES008421NINDS NIH HHS NS062836NINDS NIH HHS R01 NS062836
6 · The paper itself

Abstract

Many cancer cells have a strong requirement for glutamine. As an aid for understanding this phenomenon the (18)F-labeled 2S,4R stereoisomer of 4-fluoroglutamine [(2S,4R)4-FGln] was previously developed for in vivo positron emission tomography (PET). In the present work, comparative enzymological studies of unlabeled (2S,4R)4-FGln and its deamidated product (2S,4R)4-FGlu were conducted as an adjunct to these PET studies. Our findings are as follows: Rat kidney preparations catalyze the deamidation of (2S,4R)4-FGln. (2,4R)4-FGln and (2S,4R)4-FGlu are substrates of various aminotransferases. (2S,4R)4-FGlu is a substrate of glutamate dehydrogenase, but not of sheep brain glutamine synthetase. The compound is, however, a strong inhibitor of this enzyme. Rat liver cytosolic fractions catalyze a γ-elimination reaction with (2S,4R)4-FGlu, generating α-ketoglutarate. Coupling of a deamidase reaction with this γ-elimination reaction provides an explanation for the previous detection of (18)F(-) in tumors exposed to [(18)F](2S,4R)4-FGln. One enzyme contributing to this reaction was identified as alanine aminotransferase, which catalyzes competing γ-elimination and aminotransferase reactions with (2S,4R)4-FGlu. This appears to be the first description of an aminotransferase catalyzing a γ-elimination reaction. The present results demonstrate that (2S,4R)4-FGln and (2S,4R)4-FGlu are useful analogues for comparative studies of various glutamine- and glutamate-utilizing enzymes in normal and cancerous mammalian tissues, and suggest that tumors may metabolize (2S,4R)4-FGln in a generally similar fashion to glutamine. In plants, yeast and bacteria a major route for ammonia assimilation involves the consecutive action of glutamate synthase plus glutamine synthetase (glutamate synthase cycle). It is suggested that (2S,4R)4-FGln and (2S,4R)4-FGlu will be useful probes in studies of ammonia assimilation by the glutamate synthase pathway in these organisms. Finally, glutamine transaminases are conserved in mammals, plants and bacteria, and probably serve to close the methionine salvage pathway, thus linking nitrogen metabolism to sulfur metabolism and one-carbon metabolism. It is suggested that (2S,4R)4-FGln may be useful in studies of the methionine salvage pathway in a variety of organisms.

Indexed as

Alanine TransaminaseAmidohydrolasesAnimalsAspartate AminotransferasesGlutamate-Ammonia LigaseGlutamate DehydrogenaseGlutaminaseGlutamineHumansMethionineMiceRatsAlanine TransaminaseamidaseAmidohydrolasesAspartate AminotransferasesGlutamate-Ammonia LigaseGlutamate DehydrogenaseGlutaminaseGlutamineMethionine

Identifiers

PMID22613816
PMCPMC3389287
OpenAlexW2093818073

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.